Medical devices industry M&A deals in Q1 2020 total $1.72bn in US

22 April 2020 (Last Updated April 22nd, 2020 15:04)

Medical devices industry M&A deals in Q1 2020 total $1.72bn in US

Total medical devices industry M&A deals in Q1 2020 worth $1.72bn were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 19.5% over the previous quarter and a drop of 77.5% when compared with the last four-quarter average of $7.63bn.

The US held a 12.4% share of the global medical devices industry M&A deal value that totalled $13.89bn in Q1 2020.

In terms of deal activity, the US recorded 55 deals during Q1 2020, marking a rise of 19.6% over the previous quarter and a rise of 3.8% over the last four-quarter average.

The US medical devices industry M&A deals in Q1 2020: Top deals

The top five medical devices industry M&A deals accounted for 85.7% of the overall value during Q1 2020.

The combined value of the top five medical devices M&A deals stood at $1.47bn, against the overall value of $1.72bn recorded for the month.

The top five medical devices industry deals of Q1 2020 tracked by GlobalData were:

1) Eli Lilly and’s $1.1bn acquisition of Dermira

2) The $100m acquisition of ArthroSurface by Anika Therapeutics

3) Halma’s $97m acquisition of NovaBone Products

4) The $95m acquisition of Parcus Medical by Anika Therapeutics

5) InVitae’s acquisition of YouScript for $79.3m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.